Vaccine design and delivery approaches for COVID-19

Kiana Shahzamani(Isfahan University of Medical Sciences), Shaghayegh Haghjooy Javanmard(Isfahan University of Medical Sciences), Leila Beikmohammadi(Tehran University of Medical Sciences), Samira Bahrami(Shahid Beheshti University), Sahar Esfandyari(Tehran University of Medical Sciences), Mohammad Mehdi Ranjbar(Razi Vaccine and Serum Research Institute), Fatemeh Mahmoudian(Semnan University of Medical Sciences), Abbas Alibakhshi(Hamedan University of Medical Sciences), Shahrzad Ahangarzadeh(Isfahan University of Medical Sciences), Elmira Mohammadi(Isfahan University of Medical Sciences)
International Immunopharmacology
August 22, 2021
10.1016/j.intimp.2021.108086
Cited by 37

Related Papers

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
|JAMA|2022|909
Aptamers as an approach to targeted cancer therapy
|Cancer Cell International|2024|101
A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021
|medRxiv|2022|86
Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma
|Journal of Assisted Reproduction and Genetics|2019|21
Deciphering Host–Virus Interactions and Advancing Therapeutics for Chronic Viral Infection
|Viruses|2025|18